LifeNet Health launches vascular allograft

LifeNet Health (Virginia Beach, Va.) recently announced that it has launched its AngioGraft Aortoiliac Artery, an aortoiliac allograft that gives surgeons pressurized sizing with flaccid measurements.

Both measurements allow surgeons to use the graft that best matches their patient’s anatomy. The AngioGraft Aortoiliac Artery is the first allograft to have three configurations that are tailored to surgical techniques, according to the company.

“The pressurized diameter was accurate and was an excellent fit for my patient,” Rafael Malgor, a vascular surgeon with Sentara Vascular Specialists, said in a press release. “Having this measurement in advance will help save valuable time in the operating room.”

The allografts are used in patients who have had an infection in their native aorta or in previously implanted synthetic graft. Allografts are important because human tissue has a natural resistance to infection. LifeNet Health reports that patients who are undergoing aortic reconstruction have lower levels of morbidity and mortality if treated with allograft aortoiliac arteries.

Distention in arteries varies between patients because of arterial pressure, so it is hard to surgeons to decide what kind of graft to use. This results in graft-to-patient mismatch because the allografts are only measure in the flaccid state, which leaves clinicians guessing what its pressurized size is. LifeNet Health suggests its new AngioGraft Aortoiliac Artery helps take away the guesswork and prevents mismatched grafts.

“This graft was developed with the acute nature of these procedures in mind,” Daniel Osborne, VP of global marketing at LifeNet Health, said. “We heard from clinicians about the challenges they face in aortic reconstruction and we are proud to bring them a graft with greater precision to help them save the lives of critically-ill patients.”